Contact
searchSearch
HMP Global

General Neurology Topic Center

Recent News and Updates

Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
News
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
08/19/2024
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric...
08/19/2024
Neurology
stroke
News
FDA-Cleared Endovascular Technology Unveiled at SNIS 21st Annual Meeting
08/09/2024
At the SNIS 21st Annual Meeting, Radical Catheter Technologies presented their Neurovascular Radical Catheter, which obtained 510(k) clearance from the US FDA FDA for its novel endovascular technology.
At the SNIS 21st Annual Meeting, Radical Catheter Technologies presented their Neurovascular Radical Catheter, which obtained 510(k) clearance from the US FDA FDA for its novel endovascular technology.
At the SNIS 21st Annual Meeting,...
08/09/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C
News
Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C
07/16/2024
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Children and adolescents with...
07/16/2024
Neurology
two illustrated heads in profile, one orange and one blue, with slight overlap between the two in the middle of the picture
News
Prolonged Depression in Young Adulthood May Hurt Cognition in Middle Age
06/18/2024
Prolonged depressive symptoms beginning in young adulthood are associated with worse cognitive function in midlife, especially in Black adults. Researchers published their findings in Neurology.
Prolonged depressive symptoms beginning in young adulthood are associated with worse cognitive function in midlife, especially in Black adults. Researchers published their findings in Neurology.
Prolonged depressive symptoms...
06/18/2024
Neurology
brain imaging
Almost One-Quarter of Children With Head Trauma Symptoms Not Checked for Concussion, Brain Injury
05/03/2024
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant...
05/03/2024
Neurology
Ultrasound Neuromodulation Shows Potential for Brain Disorder Treatment
News
Ultrasound Neuromodulation Shows Potential for Brain Disorder Treatment
03/26/2024
Researchers used a novel method of noninvasive brain stimulation called patterned low-intensity low-frequency ultrasound stimulation to induce long-lasting changes in the brain function of mice, according to a study published in Science...
Researchers used a novel method of noninvasive brain stimulation called patterned low-intensity low-frequency ultrasound stimulation to induce long-lasting changes in the brain function of mice, according to a study published in Science...
Researchers used a novel method...
03/26/2024
Neurology
quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
From Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News
Maternal COVID-19 Vaccination While Pregnant Not Associated With Neurodevelopmental Delay at 18 Months
03/12/2024
Maternal vaccination against COVID-19 during pregnancy was found safe for offspring up to 18 months according to neurodevelopment measures. Results from the prospective cohort study were published in JAMA Pediatrics.
Maternal vaccination against COVID-19 during pregnancy was found safe for offspring up to 18 months according to neurodevelopment measures. Results from the prospective cohort study were published in JAMA Pediatrics.
Maternal vaccination against...
03/12/2024
Neurology

Quizzes

quiz
Quiz
Age-Response Connection in Multilocus Sequential rTMS Therapy for Tinnitus With Comorbid Mental Health Conditions
03/18/2024
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study, which patient group is more likely to initially show less improvement in tinnitus symptoms when undergoing multilocus sequential rTMS therapy?
According to a recent study,...
03/18/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
How does serious mental illness affect risk of death after COVID-19 infection?
11/29/2023
Test your clinical knowledge with this quiz!
Test your clinical knowledge with this quiz!
Test your clinical knowledge...
11/29/2023
Neurology
Pencils spell out quiz.
Quiz
What kind of brain inflammation does COVID-19 infection cause?
04/12/2023
Test your neurology knowledge with this quiz!
Test your neurology knowledge with this quiz!
Test your neurology knowledge...
04/12/2023
Neurology
Some heart-healthy foods, including fruits and vegetables.
Quiz
How much can a heart-healthy lifestyle reduce stroke risk in those with high genetic risk?
08/12/2022
Take the quiz to test your neurology knowledge!
Take the quiz to test your neurology knowledge!
Take the quiz to test your...
08/12/2022
Neurology
People raising hands to answer question.
Quiz
Which conditions did access to medical marijuana improve?
07/15/2022
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
07/15/2022
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
Anxiety and Parkinson Disease Development in Older Adults
09/24/2024
Test your knowledge of recent research with this quiz!
Test your knowledge of recent research with this quiz!
Test your knowledge of recent...
09/24/2024
Neurology
Pregnant heart
Clinical Refresh Quiz
Updated Guidelines for Antiseizure Medications in People With Epilepsy of Childbearing Potential
09/06/2024
Are you up-to-date on the most recent recommendations for managing antiseizure medications in people with epilepsy of childbearing potential? Take this short, 2-part quiz to refresh your understanding of the evidence-based guidelines.
Are you up-to-date on the most recent recommendations for managing antiseizure medications in people with epilepsy of childbearing potential? Take this short, 2-part quiz to refresh your understanding of the evidence-based guidelines.
Are you up-to-date on the most...
09/06/2024
Neurology
Pop quiz written on a blackboard with white chalk
Quiz
FDA-Approved Options for Pediatric Narcolepsy
08/15/2024
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
08/15/2024
Neurology
people looking quizzical with question marks over their head
Expert Insights Quiz
First-Line Treatment Options for Insomnia
08/06/2024
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
08/06/2024
Neurology
quiz
Quiz
Percentage of Patients With Major or Mild Frontotemporal NCD Found With Alzheimer Disease Pathology at Autopsy
07/11/2024
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients...
07/11/2024
Psych Congress Network
NLN Quiz
Quiz
ADHD and Tourettes Syndrome Comorbidities, Treatment
07/03/2024
Comorbid ADHD is common in people with Tourettes syndrome (TS), with what range of prevalence? In children with tics and ADHD, what treatment does not worsen tics and reduces ADHD symptoms? Find out!
Comorbid ADHD is common in people with Tourettes syndrome (TS), with what range of prevalence? In children with tics and ADHD, what treatment does not worsen tics and reduces ADHD symptoms? Find out!
Comorbid ADHD is common in...
07/03/2024
Neurology
restless legs syndrom
Quiz
Restless Leg Syndrome in the United States
06/14/2024
Refresh your knowledge of a common sleep disorder with this quiz!
Refresh your knowledge of a common sleep disorder with this quiz!
Refresh your knowledge of a...
06/14/2024
Neurology
Oxygen Saturation and Late-Onset Epilepsy
Quiz
Oxygen Saturation and Late-Onset Epilepsy
05/29/2024
Do you remember this study? Quiz yourself and see!
Do you remember this study? Quiz yourself and see!
Do you remember this study? Quiz...
05/29/2024
Neurology
people looking quizzical with question marks over their head
Quiz
Medication Options for Episodic Migraine
05/01/2024
Are you up on the latest research in the migraine space? Find out with this quick quiz!
Are you up on the latest research in the migraine space? Find out with this quick quiz!
Are you up on the latest...
05/01/2024
Neurology
Pop quiz!
Quiz
Delirium Episodes and Incident Dementia Diagnosis
04/23/2024
Put your neurology knowledge to the test with this quiz!
Put your neurology knowledge to the test with this quiz!
Put your neurology knowledge to...
04/23/2024
Neurology

News

Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
News
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
08/19/2024
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric...
08/19/2024
Neurology
stroke
News
FDA-Cleared Endovascular Technology Unveiled at SNIS 21st Annual Meeting
08/09/2024
At the SNIS 21st Annual Meeting, Radical Catheter Technologies presented their Neurovascular Radical Catheter, which obtained 510(k) clearance from the US FDA FDA for its novel endovascular technology.
At the SNIS 21st Annual Meeting, Radical Catheter Technologies presented their Neurovascular Radical Catheter, which obtained 510(k) clearance from the US FDA FDA for its novel endovascular technology.
At the SNIS 21st Annual Meeting,...
08/09/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C
News
Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C
07/16/2024
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Children and adolescents with...
07/16/2024
Neurology
two illustrated heads in profile, one orange and one blue, with slight overlap between the two in the middle of the picture
News
Prolonged Depression in Young Adulthood May Hurt Cognition in Middle Age
06/18/2024
Prolonged depressive symptoms beginning in young adulthood are associated with worse cognitive function in midlife, especially in Black adults. Researchers published their findings in Neurology.
Prolonged depressive symptoms beginning in young adulthood are associated with worse cognitive function in midlife, especially in Black adults. Researchers published their findings in Neurology.
Prolonged depressive symptoms...
06/18/2024
Neurology
Ultrasound Neuromodulation Shows Potential for Brain Disorder Treatment
News
Ultrasound Neuromodulation Shows Potential for Brain Disorder Treatment
03/26/2024
Researchers used a novel method of noninvasive brain stimulation called patterned low-intensity low-frequency ultrasound stimulation to induce long-lasting changes in the brain function of mice, according to a study published in Science...
Researchers used a novel method of noninvasive brain stimulation called patterned low-intensity low-frequency ultrasound stimulation to induce long-lasting changes in the brain function of mice, according to a study published in Science...
Researchers used a novel method...
03/26/2024
Neurology
A teddy bear against a blue background wearing a mask and stethoscope.
News
Maternal COVID-19 Vaccination While Pregnant Not Associated With Neurodevelopmental Delay at 18 Months
03/12/2024
Maternal vaccination against COVID-19 during pregnancy was found safe for offspring up to 18 months according to neurodevelopment measures. Results from the prospective cohort study were published in JAMA Pediatrics.
Maternal vaccination against COVID-19 during pregnancy was found safe for offspring up to 18 months according to neurodevelopment measures. Results from the prospective cohort study were published in JAMA Pediatrics.
Maternal vaccination against...
03/12/2024
Neurology
An illustrated face in profile, wearing a mask
News
Cognitive Deficits Observed in Aftermath of Both Short- and Long-COVID-19
03/07/2024
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following...
03/07/2024
Neurology
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

News

Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
An older woman sits alone
News
New-Onset Anxiety Increases PD Risk in Adults 50 and Older
08/27/2024
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.
The risk of developing Parkinson...
08/27/2024
Neurology
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
News
Cognitive and Psychiatric Burden Substantial Up to 3 Years After Acute COVID-19
08/19/2024
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric symptom trajectories increased over 2 to 3 years after hospitalization for acute COVID-19, according to a study published in Lancet Psychiatry.
Cognitive and psychiatric...
08/19/2024
Neurology
stroke
News
FDA-Cleared Endovascular Technology Unveiled at SNIS 21st Annual Meeting
08/09/2024
At the SNIS 21st Annual Meeting, Radical Catheter Technologies presented their Neurovascular Radical Catheter, which obtained 510(k) clearance from the US FDA FDA for its novel endovascular technology.
At the SNIS 21st Annual Meeting, Radical Catheter Technologies presented their Neurovascular Radical Catheter, which obtained 510(k) clearance from the US FDA FDA for its novel endovascular technology.
At the SNIS 21st Annual Meeting,...
08/09/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C
News
Pediatric Neurological Manifestations Tied to SARS-CoV-2 and MIS-C
07/16/2024
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Children and adolescents with acute SARS-CoV-2 or multisystem inflammatory syndrome (MIS-C) could be at high risk for long-term impairment and severe neurological manifestations and may benefit from further screening and intervention.
Children and adolescents with...
07/16/2024
Neurology
two illustrated heads in profile, one orange and one blue, with slight overlap between the two in the middle of the picture
News
Prolonged Depression in Young Adulthood May Hurt Cognition in Middle Age
06/18/2024
Prolonged depressive symptoms beginning in young adulthood are associated with worse cognitive function in midlife, especially in Black adults. Researchers published their findings in Neurology.
Prolonged depressive symptoms beginning in young adulthood are associated with worse cognitive function in midlife, especially in Black adults. Researchers published their findings in Neurology.
Prolonged depressive symptoms...
06/18/2024
Neurology
Ultrasound Neuromodulation Shows Potential for Brain Disorder Treatment
News
Ultrasound Neuromodulation Shows Potential for Brain Disorder Treatment
03/26/2024
Researchers used a novel method of noninvasive brain stimulation called patterned low-intensity low-frequency ultrasound stimulation to induce long-lasting changes in the brain function of mice, according to a study published in Science...
Researchers used a novel method of noninvasive brain stimulation called patterned low-intensity low-frequency ultrasound stimulation to induce long-lasting changes in the brain function of mice, according to a study published in Science...
Researchers used a novel method...
03/26/2024
Neurology
A teddy bear against a blue background wearing a mask and stethoscope.
News
Maternal COVID-19 Vaccination While Pregnant Not Associated With Neurodevelopmental Delay at 18 Months
03/12/2024
Maternal vaccination against COVID-19 during pregnancy was found safe for offspring up to 18 months according to neurodevelopment measures. Results from the prospective cohort study were published in JAMA Pediatrics.
Maternal vaccination against COVID-19 during pregnancy was found safe for offspring up to 18 months according to neurodevelopment measures. Results from the prospective cohort study were published in JAMA Pediatrics.
Maternal vaccination against...
03/12/2024
Neurology
An illustrated face in profile, wearing a mask
News
Cognitive Deficits Observed in Aftermath of Both Short- and Long-COVID-19
03/07/2024
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following...
03/07/2024
Neurology
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use